Jeff Ross, Ph.D., CEO Oct. 11 | 5:30pm | Ecolab Life Sciences Ballroom  Eden Prairie, MN (NASDAQ: MIRO) Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary...

Shankar Musunuri, Ph.D., Chairman, CEO & Co-Founder Oct. 11 | 5:15pm | Aseptic Technologies Ballroom  Malvern, PA (NASDAQ: OCGN) Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the...

Kevin Caldwell, Co-Founder and CEO Oct. 11 | 5:15pm | Ecolab Life Sciences Ballroom  San Francisco, CA (Private) Ossium is a bioengineering company that has developed a novel platform for processing, banking, and deploying bone marrow-derived cell therapies at an industrial scale. Ossium uses stem cell science to make...

Steven Yatomi-Clarke, CEO and Managing Director Oct. 10 | 4:15pm | Ecolab Life Sciences Ballroom  Melbourne, Australia (NASDAQ: PTX) Prescient has two platforms to overcome the limitations of current cell therapies. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi- antigen targeting with a single...

Tracey Lodie, Ph.D., Chief Scientific Officer Oct. 11 | 4:00pm | Ecolab Life Sciences Ballroom  London, UK (Private) Quell Therapeutics Ltd is a leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system. Quell has raised over $300M capital to...

Derek Hicks, Executive Vice President, Chief Business Officer Oct. 10 | 11:00am | Ecolab Life Sciences Ballroom  Cambridge, MA (NASDAQ: NTLA) Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. To fully realize the transformative potential of CRISPR-based technologies, Intellia is...

Tony Ward, Chief Technology Officer Oct. 11 | 5:45pm | Ecolab Life Sciences Ballroom  Carlsbad, CA  (Private)   Curate Biosciences – Highest Quality Starting Material Matters in Cell Therapy, The Curate® Cell Processing System isolates leukocytes using Deterministic Cell Separation™ (DCS), an advanced, highspeed microfluidic technology that gently separates cells...

Rodolphe Clerval, CEO   Oct. 10 | 1:15pm | Ecolab Life Sciences Ballroom  Paris, France  (Private)  Coave Tx is a genetic medicine company focused on CNS and Ocular space, based on a unique delivery platform enabling chemical conjugation of rationally designed ligands onto viral and non-viral vectors, with demonstrated superiority...

Matthew Lakelin, Ph.D., Vice President, Scientific Affairs & Product Development, Co-Founder Oct. 12 | 10:00am | Ecolab Life Sciences Ballroom  Cardiff, UK (Private) TrakCel is the first provider of integrated cellular orchestration solutions for the precise management, control and tracking of cell & gene therapy products. With the largest...

Gitesh Dubal, Executive Vice President, Chief Marketing Officer Oct. 10 | 5:45pm | Ecolab Life Sciences Ballroom  Milwaukee, WI (Private) Versiti supports biopharma and cell therapy companies through starting biomaterial provision, as well as specialty CRO services and IRB review. Biomaterial Provision: We provide a reliable supply of starting...

By using this website you agree to accept our Privacy Policy and Terms & Conditions